Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine plus Rituximab without Autologous Transplant

被引：9

作者：

Hill, Brian T. ^{[1
]}

Switchenko, Jeffrey M. ^{[2
]}

Martin, Peter ^{[3
]}

Churnetski, Michael C. ^{[4
]}

Sawalha, Yazeed ^{[5
]}

Goyal, Subir ^{[2
]}

Shanmugasundaram, Krithika ^{[6
]}

Calzada, Oscar ^{[7
]}

Kolla, Bhaskar ^{[8
]}

Bachanova, Veronika ^{[8
]}

Gerson, James N. ^{[9
]}

Barta, Stefan K. ^{[9
]}

Gordon, Max J. ^{[10
]}

Danilov, Alexey ^{[11
]}

Grover, Natalie S. ^{[12
]}

Mathews, Stephanie ^{[13
]}

Burkart, Madelyn ^{[14
,15
]}

Karmali, Reem ^{[16
]}

Ghosh, Nilanjan ^{[17
]}

Park, Steven I. ^{[18
]}

Epperla, Narendranath ^{[19
]}

Bond, David A. ^{[20
]}

Badar, Talha ^{[21
]}

Blum, Kristie A. ^{[22
]}

Guo, Jin ^{[23
]}

Hamadani, Mehdi ^{[24
]}

Fenske, Timothy S. ^{[25
]}

Malecek, Mary-Kate ^{[26
]}

Kahl, Brad S. ^{[26
]}

Flowers, Christopher R. ^{[27
]}

Cohen, Jonathon B. ^{[28
]}

机构：

[1] Cleveland Clin Fdn, Taussig Canc Inst, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA

[2] Emory Univ, Winship Canc Inst, Biostat & Bioinformat, Atlanta, GA 30322 USA

[3] Weill Cornell Med New York Presbyterian Hosp, New York, NY USA

[4] Emory Univ, Winship Canc Inst, Ctr Med, Atlanta, GA 30322 USA

[5] Cleveland Clin, Taussig Canc Inst, Dept Med & Hematol Oncol, Cleveland, OH 44106 USA

[6] Emory Univ, Sch Med, Atlanta, GA USA

[7] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

[8] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA

[9] Univ Penn, Lymphoma Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[10] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[11] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[12] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA

[13] Univ N Carolina, Chapel Hill, NC 27515 USA

[14] Northwestern Univ, Chicago, IL 60611 USA

[15] Northwestern Hosp, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA

[16] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA

[17] Atrium Hlth, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA

[18] Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA

[19] Marshfield Clin Fdn Med Res & Educ, Columbus, OH USA

[20] Ohio State Univ Hosp, James Canc Ctr, Columbus, OH 43210 USA

[21] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[22] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[23] Weill Cornell Med, Dept Med, New York, NY USA

[24] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[25] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA

[26] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA

[27] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[28] Emory Univ, Atlanta, GA 30322 USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-129404

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1525

引用

页数：6

共 50 条

[31] Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era [J].

Gerson, James Nathan ;

Barta, Stefan Klaus ;

Villa, Diego ;

Gerrie, Alina S. ;

Li, Shaoying ;

Medeiros, Jeffrey ;

Wang, Michael ;

Hill, Brian T. ;

Sawalha, Yazeed ;

Hernandez-Ilizaliturri, Francisco J. ;

Kothari, Shalin ;

Vose, Julie M. ;

Fenske, Timothy S. ;

Rao, Swapna Narayana ;

Maddocks, Kami J. ;

Bond, David A. ;

Lansigan, Frederick ;

Burns, Timothy ;

Donovan, Alexandra M. ;

Mehta, Amitkumar ;

Reddy, Nishitha ;

Landsburg, Daniel J. ;

Glenn, Martha ;

Inwards, David James ;

Ristow, Kay ;

Karmali, Reem ;

Kaplan, Jason ;

Umyarova, Elvira ;

Pulluri, Bhargavi ;

Amengual, Jennifer E. ;

Lue, Jennifer Kimberly ;

Caimi, Paolo ;

Cohen, Jonathon B. ;

Calzada, Oscar ;

Handorf, Elizabeth ;

Anderson, Jennifer Kelly ;

Chapani, Parv ;

Bachanova, Veronika ;

Rajguru, Saurabh ;

Churnetski, Michael C. ;

Diefenbach, Catherine ;

Bast, Martin ;

Kovach, Alexandra E. .

BLOOD, 2017, 130

[32] Rituximab maintenance therapy post autologous stem cell transplant (ASCT) [J].

Rice, R. D. ;

Moskowitz, C. H. .

EJC SUPPLEMENTS, 2005, 3 (02) :284-284

[33] Rituximab, Bendamustine and Cytarabine (R-BAC) Is a Very Active Regimen In Patients with Mantle Cell Lymphoma Not Eligible for Intensive Chemotherapy or Autologous Transplant [J].

Visco, Carlo ;

Zambello, Renato ;

Paolini, Rossella ;

Finotto, Silvia ;

Zanotti, Roberta ;

Zaja, Francesco ;

Nadali, Gianpaolo ;

Trentin, Livio ;

Rodella, Elisabetta ;

Lissandrini, Laura ;

Semenzato, Gianpietro ;

Pizzolo, Giovanni ;

Rodeghiero, Francesco .

BLOOD, 2011, 118 (21) :1150-1150

[34] Interim Analysis of a Phase 2 Study of Bortezomib Plus Rituximab Maintenance Therapy in Patients with Mantle Cell Lymphoma Status Post Autologous Stem Cell Transplantation [J].

Chen, Robert ;

Palmer, Joycelynne ;

Holmberg, Leona ;

Alluin, Jessica ;

Chomchan, Pritsana ;

Popplewell, Leslie L. ;

Siddiqi, Tanya ;

Thomas, Sandra H. ;

Irenze, Kathryn ;

Nademanee, Auayporn P. ;

Spielberger, Ricardo ;

Rossi, John J. ;

Rosen, Steven T. ;

Kwak, Larry W. ;

Forman, Stephen J. .

BLOOD, 2015, 126 (23)

[35] Rituximab Maintenance Therapy Until Progression After Rituximab and Chemotherapy Induction in Patients With Follicular Lymphoma [J].

Yared, Jean ;

Kimball, Amy ;

Baer, Maria R. ;

Bahrain, Huzefa ;

Auerbach, Michael .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (03) :253-257

[36] RITUXIMAB, BENDAMUSTINE AND CYTARABINE AS INDUCTION THERAPY IN ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA: A PHASE 2 STUDY FROM THE FONDAZIONE ITALIANA LINFOMI [J].

Visco, C. ;

Chiappella, A. ;

Franceschetti, S. ;

Patti, C. ;

Ferrero, S. ;

Barbero, D. ;

Evangelista, A. ;

Spina, M. ;

Molinari, A. ;

Rigacci, L. ;

Tani, M. ;

Di Rocco, A. ;

Pinotti, G. ;

Fabbri, A. ;

Zambello, R. ;

Finotto, S. ;

Gotti, M. ;

Carella, A. M. ;

Salvi, F. ;

Pileri, S. A. ;

Ladetto, M. ;

Zaja, F. ;

Gaidano, G. ;

Vitolo, U. ;

Rodeghiero, F. .

HAEMATOLOGICA, 2015, 100 :4-4

[37] Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma [J].

S Dietrich ;

J Weidle ;

M Rieger ;

J Meissner ;

A Radujkovic ;

A D Ho ;

P Dreger ;

M Witzens-Harig .

Leukemia, 2014, 28 :708-709

[38] Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma [J].

Dietrich, S. ;

Weidle, J. ;

Rieger, M. ;

Meissner, J. ;

Radujkovic, A. ;

Ho, A. D. ;

Dreger, P. ;

Witzens-Harig, M. .

LEUKEMIA, 2014, 28 (03) :708-709

[39] Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma [J].

Toyama, Kazuhiro ;

Takezaki, Toshiaki ;

Honda, Akira ;

Kogure, Yasunori ;

Chiba, Akira ;

Nakamura, Fumihiko ;

Nakazaki, Kumi ;

Kurokawa, Mineo .

BLOOD, 2019, 134

[40] COST EFFECTIVENESS OF OBINUTUZUMAB PLUS BENDAMUSTINE VS BENDAMUSTINE ALONE FOR PATIENTS WHO DID NOT RESPOND OR PROGRESSED DURING OR AFTER RITUXIMAB OR A RITUXIMAB CONTAINING REGIMENT IN TURKEY [J].

Erdogan-Ciftci, E. ;

Yanik, L. ;

Ersoy, Akyol B. ;

Krivasi, T. .

VALUE IN HEALTH, 2019, 22 :S481-S481

← 1 2 3 4 5 →